Age-related macular degeneration (AMD) is a neurodegenerative disease of the central retina, resulting in irreversible vision loss. It is recognised as the leading cause of blindness in the Western world, primarily affecting those over the age of 50, with an expected prevalence of 288 million people by 2040. Inflammation is a cellular response that has been implicated in the pathogenesis of AMD. There are currently no treatments available for the more prevalent non-exudative form of AMD ('dry'...[Show more]
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.